CVRx price target raised to $22 from $20 at Craig-Hallum
Craig-Hallum raised the firm’s price target on CVRx (CVRX) to $22 from $20 and keeps a Buy rating on the shares. CVRx posted a modest beat in ...
CVRx (CVRX) Expected to Beat Earnings Estimates: Should You Buy?
CVRx (CVRX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Hosted on MSN2d
William Blair Upgrades CVRx (CVRX)
Fintel reports that on January 14, 2025, William Blair upgraded their outlook for CVRx (NasdaqGS:CVRX) from Market Perform to ...
CVRx upgraded by William Blair to outperform
William Blair has upgraded CVRx (NASDAQ:CVRX) to outperform from market perform, citing utilization improvements and ...
Business Insider3d
William Blair upgrades CVRx on stabilization of business
William Blair analyst Margaret Kaczor upgraded CVRx (CVRX) to Outperform from Market Perform without a price target With now several solid quarters behind it following ithe Q1 of 2024 miss and ...
CVRx says total Q4 revenue is expected to be between $15.2M and $15.3M
CVRx anticipates a 35% increase in Q4 2024 revenue and a 30% increase in FY24 revenue, with shares down 1.55% premarket.
CVRx Reports Preliminary Fourth Quarter and Fiscal Year 2024 Financial Results and Issues Fiscal 2025 Guidance
Fourth quarter revenue expected to be $15.2 million to $15.3 million, representing growth of 35%Full year revenue expected to ...
Taiwan News24d
CVRx to Present at the 43rd Annual J.P. Morgan Healthcare Conference
MINNEAPOLIS, Dec. 23, 2024 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a commercial-stage medical device company, today announced that the management team will present at the 43 rd Annual ...